tradingkey.logo
搜尋

Sonoma Pharmaceuticals Inc

SNOA
添加自選
1.210USD
0.0000.00%
收盤 07/02, 13:00美東報價延遲15分鐘
2.09M總市值
虧損本益比TTM

關於 Sonoma Pharmaceuticals Inc 公司

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc簡介

公司代碼SNOA
公司名稱Sonoma Pharmaceuticals Inc
上市日期Jan 26, 2007
CEOTrombly (Amy)
員工數量168
證券類型Ordinary Share
年結日Jan 26
公司地址5445 Conestoga Court, Suite 150
城市BOULDER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編80301
電話18007599305
網址https://sonomapharma.com/
公司代碼SNOA
上市日期Jan 26, 2007
CEOTrombly (Amy)

Sonoma Pharmaceuticals Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--

常見問題

Sonoma Pharmaceuticals Inc的前五大股東是誰?

Sonoma Pharmaceuticals Inc的前五大股東如下:Dr. Jay E. Birnbaum, Ph.D.

有多少機構持有Sonoma Pharmaceuticals Inc(SNOA)的股份?

截至2026Q1,共有40家機構持有Sonoma Pharmaceuticals Inc的股份,合計持有的股份價值約為127.80K,占公司總股份的3.68% 。與2025Q4相比,機構持股有所增加,增幅為-34692.00。

哪個業務部門對Sonoma Pharmaceuticals Inc的收入貢獻最大?

在2026Q1,Human Care業務部門對Sonoma Pharmaceuticals Inc的收入貢獻最大,創收3.86M,占總收入的88.83% 。